SCHEMBL1939205

SCHEMBL1939205

CN(CCO)S(=O)(=O)c1cc(C(N)=O)c(Cl)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTO1 P78417 1/20 0.42
KMT2A Q03164 5/20 0.39
RXFP1 Q9HBX9 1/20 0.39
ALDH1A1 P00352 5/20 0.38
CFTR P13569 4/20 0.37
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
HTT P42858 1/20 0.36
CHEK1 O14757 1/20 0.34
CA2 P00918 2/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA3 P07451 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA13 Q8N1Q1 1/20 0.34
CA14 Q9ULX7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1939622 0.86 VCAM1 (0.37) GSTO1CFTRCHEK1CA2CA12
SCHEMBL4868155 0.84 CA2 (0.34) GSTO1CHEK1CA2CA12CA1
SCHEMBL1938882 0.83 GSTO1 (0.42) GSTO1KMT2ARXFP1ALDH1A1KDM4E
SCHEMBL1938669 0.75 VCAM1 (0.46) GSTO1KMT2ARXFP1ALDH1A1KDM4E
SCHEMBL1939691 0.74 ALDH1A1 (0.49) KMT2AALDH1A1CHEK1CA2CA12
SCHEMBL1938333 0.73 CA2 (0.47) KMT2ACA2CA12CA1CA3
SCHEMBL1938337 0.72 GSTO1 (0.39) GSTO1KMT2AALDH1A1MEN1HTT
SCHEMBL1940129 0.72 KDM4E (0.37) ALDH1A1CFTRKDM4ECA2CA12
SCHEMBL1940985 0.72 CFTR (0.35) KMT2AALDH1A1CFTRKDM4ECA2
SCHEMBL1940126 0.69 PSEN1 (0.35) KMT2ACA2CA12CA1CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851225-B1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2011-06-15 EP claimed
JP-2008530042-A 2008-08-07 JP claimed
US-7361659-B2 Pyrrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-04-22 US claimed
EP-1851225-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2007-11-07 EP claimed
US-20060183756-A1 Pyrrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2006-08-17 US claimed
WO-2006084634-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-08-17 WO claimed
US-7361659-B2 Pyrrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-04-22 US disclosed
EP-1851225-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2007-11-07 EP disclosed
US-20060183756-A1 Pyrrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2006-08-17 US disclosed
WO-2006084634-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183756-A1 Pyrrazolo-pyrimidine derivatives GRM1, GRM2, GRM3 GSTO1 2705/4885KMT2A 2513/4885RXFP1 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.